BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21819368)

  • 1. Thiopurine S-methyltransferase polymorphism in Iranian kidney transplant recipients.
    Aghdaie MH; Azarpira N; Geramizadeh B; Sagheb M; Darai M; Rahsaz M; Malekhoseini SA
    Exp Clin Transplant; 2011 Aug; 9(4):241-6. PubMed ID: 21819368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
    Kurzawski M; Dziewanowski K; Gawrońska-Szklarz B; Domański L; Droździk M
    Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.
    Song DK; Zhao J; Zhang LR
    J Clin Pharm Ther; 2006 Dec; 31(6):627-35. PubMed ID: 17176368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
    Cao Q; Zhu Q; Shang Y; Gao M; Si J
    Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of thiopurine S-methyltransferase polymorphisms on azathioprine dose 1 year after renal transplantation.
    Fabre MA; Jones DC; Bunce M; Morris PJ; Friend PJ; Welsh KI; Marshall SE
    Transpl Int; 2004 Oct; 17(9):531-9. PubMed ID: 15349717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiopurine S-methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients.
    Gazouli M; Pachoula I; Panayotou I; Mantzaris G; Syriopoulou VP; Goutas N; Vlachodimitropoulos D; Anagnou NP; Roma-Giannikou E
    J Clin Pharm Ther; 2010 Feb; 35(1):93-7. PubMed ID: 20175817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between thiopurine S-methyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients.
    Xin HW; Xiong H; Wu XC; Li Q; Xiong L; Yu AR
    Eur J Clin Pharmacol; 2009 Mar; 65(3):249-55. PubMed ID: 19048245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thiopurine S-methyltransferase gene polymorphism in Chilean blood donors].
    Alvarez L L; Venegas S M; Larrondo L M; Becerra B N; Castro L A; Quera P R
    Rev Med Chil; 2009 Feb; 137(2):185-92. PubMed ID: 19543639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
    De Ridder L; Van Dieren JM; Van Deventer HJ; Stokkers PC; Van der Woude JC; Van Vuuren AJ; Benninga MA; Escher JC; Hommes DW
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1137-41. PubMed ID: 16611274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency and significance of thiopurine S-methyltransferase gene polymorphisms in azathioprine-treated renal transplant recipients.
    Moloney FJ; Dicker P; Conlon PJ; Shields DC; Murphy GM
    Br J Dermatol; 2006 Jun; 154(6):1199-200. PubMed ID: 16704656
    [No Abstract]   [Full Text] [Related]  

  • 11. An audit of thiopurine methyltransferase genotyping and phenotyping before intended azathioprine treatment for dermatological conditions.
    Vestergaard T; Bygum A
    Clin Exp Dermatol; 2010 Mar; 35(2):140-4. PubMed ID: 19663853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between metabolic enzyme genotype of azathioprine and drug tolerance in patients with rheumatic diseases].
    Zhan ZP; Liang LQ; Yang XY; Wang YX; Huang M; Li H
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1734-7. PubMed ID: 17919375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand.
    Vannaprasaht S; Angsuthum S; Avihingsanon Y; Sirivongs D; Pongskul C; Makarawate P; Praditpornsilpa K; Tassaneeyakul W; Tassaneeyakul W
    Clin Ther; 2009 Jul; 31(7):1524-33. PubMed ID: 19695401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease.
    Winter J; Walker A; Shapiro D; Gaffney D; Spooner RJ; Mills PR
    Aliment Pharmacol Ther; 2004 Sep; 20(6):593-9. PubMed ID: 15352906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of thiopurine S-Methyltransferase gene polymorphisms for prediction of azathioprine toxicity.
    Kolorz M; Bartosova L; Hosek J; Dvorackova D; Chylkova A; Zboril V; Batovsky M; Bartos M
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():137-42. PubMed ID: 20027160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of thiopurine S-methyltransferase (TPMT) alleles in southeast Iranian population.
    Bahari A; Hashemi M; Bari Z; Moazeni-Roodi A; Kaykhaei MA; Narouie B
    Nucleosides Nucleotides Nucleic Acids; 2010 Mar; 29(3):237-44. PubMed ID: 20408054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic polymorphisms of thiopurine methyltransferase and incidence of adverse events in patients with medical indication of azathioprine].
    Buhl MA; Gómez G; Collado MV; Oddo EM; Khoury M; Azurmendi PJ; Sarano J
    Medicina (B Aires); 2018; 78(2):65-70. PubMed ID: 29659353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
    Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
    Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiopurine S-methyltransferase genetic polymorphism in the Thai population.
    Srimartpirom S; Tassaneeyakul W; Kukongviriyapan V; Tassaneeyakul W
    Br J Clin Pharmacol; 2004 Jul; 58(1):66-70. PubMed ID: 15206995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.
    Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV
    J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.